Production of sterols in modified yeast
AssigneeDsm IP Assets B.V.
InventorsHans-Peter HOHMANN, Regina LEBER, Martin LEHMANN, Corinna ODAR, Barbara PETSCHACHER, Harald PICHLER, Birgit PLOIER
Life of this patent
Estimating the term…
Abstract
The present invention is related to production of a sterol mix in a modified yeast cell, wherein the amount of zymosterol present in said mix is dramatically reduced or abolished via modification of sterol acyltransferase activity within said yeast. The modified yeast cell can be used for production of vitamin D3 or derivatives and/or metabolites thereof.
Claims11
A yeast cell in which ERG5 and ERG6 are inactivated, wherein the sterol acyltransferase isoform ARE2 activity has been reduced or abolished, said yeast cell being used for the production of a sterol mix comprising cholesta-5,7,24(25)-trienol and zymosterol, wherein the percentage of zymosterol within said sterol mix is about 10% or less based on the total amount of sterols produced by said yeast cell.
A yeast cell in which ERG5 and ERG6 are inactivated, wherein the activity of endogenous ARE2 has been reduced or abolished, said yeast cell being used for the production of a sterol mix comprising cholesta-5,7,24(25)-trienol and zymosterol, wherein the percentage of cholesta-5,7,24(25)-trienol is about 75% or more based on the total amount of sterols produced by said yeast cell.
A yeast cell in which ERG5 and ERG6 are inactivated, wherein the ARE2 activity has been reduced or abolished, said yeast cell being used for the production of a sterol mix comprising cholesta-5,7,24(25)-trienol and zymosterol, wherein the ratio between cholesta-5,7,24(25)-trienol and zymosterol present in the sterol mix is in the range of about 7 to about 1.
A process for decreasing the amount of zymosterol produced by a yeast cell by at least 4-times, said process comprising:
- (a) providing a yeast cell, in which ERG5 and ERG6 are inactivated,
- (b) abolishing or reducing the ARE2 activity within said yeast cell,
- wherein the reduction is compared to a yeast cell wherein ARE2 is active.
A process for the production of a sterol mix, preferably a vitamin D3-precursor, more preferably 7-DHC, in a yeast cell comprising:
- (a) inactivation of ERG5 and ERG6,
- (b) reducing or abolishing the activity of ARE2 or reducing or abolishing the activity of ARE1 and ARE2,
- (c) expressing of a heterologous enzyme selected from EC 1.3.1.72 having sterol Δ24-reductase activity on lathosterol, zymosterol or trienol, preferably plant or vertebrate sterol Δ24-reductase, more preferably vertebrate sterol Δ24-reductase;
- (d) cultivating said yeast cell under conditions suitable for sterol production;
- wherein the amount of zymosterol present in the sterol mix is about 3% or less based on the total amount of sterols.
Dependencies are inferred from the claim text.